An affordable Fc-receptor blockade method to treat patients with chronic refractory autoimmune thrombocytopenic purpura.
Ruiz-Argüelles
G J
GJ
López-Martínez
B
B
Flores-Martínez
J
J
Ruiz-Argüelles
A
A
Pérez-Romano
B
B
D000209:Acute-Phase Proteins / Q000276:immunology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000008:administration & dosage / Q000627:therapeutic use; D002675:Child, Preschool; D002908:Chronic Disease; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000191:economics; D011961:Receptors, Fc / Q000037:antagonists & inhibitors*
D000209:Acute-Phase Proteins; D000906:Antibodies; D007074:Immunoglobulin G; D011961:Receptors, Fc; C010781:acute-phase protein rho